Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
Gladstone Institutes · University of California, San Francisco · +29 more institutions
Abstract
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a grave threat to public health and the global economy. SARS-CoV-2 is closely related to the more lethal but less transmissible coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Here, we have carried out comparative viral-human protein-protein interaction and viral protein localization analyses for all three viruses. Subsequent functional genetic screening identified host factors that functionally impinge on coronavirus proliferation, including Tom70, a mitochondrial chaperone protein that interacts with both SARS-CoV-1 and SARS-CoV-2 ORF9b, an interaction we structurally…
Citation impact
- FWCI
- 15.73
- Percentile
- 100%
- References
- 108
Authors
309- DEDavid E. GordonCorresponding
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- JHJoseph HiattCorresponding
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- MBMehdi BouhaddouCorresponding
Gladstone Institutes, University of California, San Francisco, Quantitative BioSciences
- VVVeronica V. RezeljCorresponding
Centre National de la Recherche Scientifique, Institut Pasteur
- SUSvenja UlfertsCorresponding
University of Freiburg
Topics & keywords
- Coronavirus
- Virology
- Biology
- Middle East respiratory syndrome coronavirus
- Middle East respiratory syndrome
- Pandemic
- Betacoronavirus
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Good health and well-being
Funding
- NSNational Science FoundationAwards: T32GM007618, 1650113, 1019894
- UDU.S. Department of DefenseAwards: W81XWH-20-1-0270, W81XWH
- HHHoward Hughes Medical Institute
- BWBurroughs Wellcome FundAward: 1019894
- BABill and Melinda Gates FoundationAward: INV-006099
- DRDamon Runyon Cancer Research FoundationAward: DRG-2402-20
- GMGeorge Mason University
- FHF. Hoffmann-La Roche
- ISIcahn School of Medicine at Mount Sinai
- JFJPB Foundation
- GIGladstone Institutes
- GSGeorgia State University
- RFRoddenberry Foundation
- AUAugusta University
- LDLABoratoires d’EXcellence ARCANE
- OPOpen Philanthropy ProjectAwards: 2020-215611, HHSN272201400008C
- CZChan Zuckerberg Initiative
- FGFast GrantsAward: COVID19 grant
- VBVir Biotechnology
- DFDeutsche ForschungsgemeinschaftAwards: 390939984, EXC-2189, ANR-10-LABX-62-IBEID
- ANAgence Nationale de la RechercheAwards: 10-LABX-62-IBEID, ANR-10-LABX-62-IBEID, ANR-10, ANR-10-LABX-62
- NINational Institutes of HealthAwards: R01 HG009979, U19 AI135990, P01AI063302, AI150476, P01AI120943, R01AI120694, F32 CA239336, GM24485, F30AI143401, F32CA239333, P01AI120943, R01AI143292, T32GM007618, R35GM122481, U19AI135972, COVID-19, P01AI063302, P50AI150476, R01AI120694, R01AI122747, R01AI143292, U19AI135972, U19AI135990, W81XWH, R01AI122747, K99GM138753, HHSN272201400008C, ASPR-20-01495, P50AI150476, R01AI143292, U19AI135990
- DADefense Advanced Research Projects AgencyAward: HR0011-20-2-0040
- UOUniversity of California, San FranciscoAward: T32GM007618
- ARAdvanced Research Projects Agency
- BABiomedical Advanced Research and Development AuthorityAward: ASPR-20-01495
- MRMedical Research CouncilAwards: MC PC 19026, MC_PC_19026, MC_UU_00018/1, MC_UU_12016, MC_UU_12016/2, COVID-19
- BABiotechnology and Biological Sciences Research CouncilAwards: BB/L002841/1, BB/J014443/1, BB/S009566/1, S009566, BB/S009566/1, 1945669, BB/S009566/1, BB/L002841/1, BB/L002841/1, BB/J014443
- NHNational Human Genome Research InstituteAwards: HG009979, R01 HG009979
- NONIH Office of the DirectorAward: AI150476
- NCNational Cancer Institute
- NINational Institute of General Medical SciencesAwards: R01 GM24485, GM24485, U19AI135990, P50AI150476, F32GM137463, T32GM007618, R35GM122481
- NINational Institute of Allergy and Infectious DiseasesAwards: R01AI143292, R01AI128214, COVID-19, U19 AI135990, HHSN272201400008C, W81XWH-20-1-0270, U19AI135990, P01AI120943, U19AI135972, AI150476, 2020-215611, F30AI143401, P50AI150476
- NINational Institute of Neurological Disorders and StrokeAward: R01 NS089713
- DSDefense Sciences Office, DARPAAward: HR0011-19-2-0020